Breast Cancer: Early Detection

  • Ingrid Schreer
  • Jutta Lüttges


Atypical Ductal Hyperplasia Architectural Distortion Radial Scar Hypoechoic Lesion Tubular Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ellis IO, Galea M, Broughton N (1992) Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20:479–489PubMedGoogle Scholar
  2. 2.
    Rosen PP, Saigo PE, Braun DW (1989) Pathologic prognostic factors in stage I and stage II breast carcinoma: a study of 655 patients with a median follow-up of 18 years. J Clin Oncol 7:1239–1251PubMedGoogle Scholar
  3. 3.
    Sickles EA (1997) Management of lesions appearing probably benign at mammography. In: Friedrich M, Sickles EA (ed) Radiological diagnosis of breast diseases. Springer, Berlin Heidelberg New York, pp 167–172Google Scholar
  4. 4.
    Stavros AT, Thickmann D, Rapp CL et al (1995) Solid breast nodules: use of sonography to determine between benign and malignant nodules. Radiology 196:123–134PubMedGoogle Scholar
  5. 5.
    WHO Classifications of tumours (2003) Tumours of the breast and female genitale organs. IARC Press, LyonGoogle Scholar
  6. 6.
    Tabàr L (1997) In: Silverstein MJ (ed) Ductal carcinoma in situ of the breast. Lippincott, Williams and Wilkins, PhiladelphiaGoogle Scholar
  7. 7.
    Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Matino S, Gamagami P, Colbum WJ (1999) The influence of margin with on local control of ductal carcinoma in situ of the breast. New Engl J Med 340:1455–1461CrossRefPubMedGoogle Scholar
  8. 8.
    Page DL, Anderson TJ (1987) Diagnostic histopathology of the breast. New York Churchill LivingstonGoogle Scholar
  9. 9.
    Tavassoli FA, Norris HF (1990) A comparison of long-term follow-up for atypical hyperplasia and intraductal hyperplasia of the breast. Cancer 65:518PubMedGoogle Scholar
  10. 10.
    Page DL, Dupont WD, Rogers L (1988) Ductal involvement by cells of a typical lobular hyperplasia: a long-term follow-up study of cancer risk. Human Pathol 19:201–207Google Scholar
  11. 11.
    Dupont WD, Page DL (1989) Relative risk of breast cancer varies with time and diagnosis of a typical hyperplasia. Human Pathol 20:723–725CrossRefGoogle Scholar
  12. 12.
    Fisher B, Dignam J, Wolmark, Wickerham DL, Fisher ER, Mamounas E, Smith R, Begociv M, Dimitrov NV, Margolese RG, Kardinal CG, Kavanah MT, Fehrenbacher I, Oishi RH (1999) Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast an bowel project B-24 randomized controlled trial. Lancet 353: 1993–2000CrossRefPubMedGoogle Scholar
  13. 13.
    Wickerham DL, Costantino J, Fisher B, Kavanah M, Wolmark N (1999) Average annual rates of invasive an noninvasive breast cancer by history of LCIS and atypical hyperplasia for participants in the BCPT. Proc. ASCO 327Google Scholar
  14. 14.
    Cauley J, Krueger K, Eckert S, Muchmore D, Taylor Y, Scott T (1999) Raloxifen reduces breast cancer risk in postmenopausal women with osteoporosis, 40-month data from the MORE trial (Abstract #328). Proc ASCOGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Ingrid Schreer
  • Jutta Lüttges

There are no affiliations available

Personalised recommendations